» Articles » PMID: 31721811

Proteomic Profiling of the Thrombin-activated Canine Platelet Secretome (CAPS)

Overview
Journal PLoS One
Date 2019 Nov 14
PMID 31721811
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Domestic dogs share the same environment as humans, and they represent a valuable animal model to study naturally-occurring human disease. Platelet proteomics holds promise for the discovery of biomarkers that capture the contribution of platelets to the pathophysiology of many disease states, however, canine platelet proteomic studies are lacking. Our study objectives were to establish a protocol for proteomic identification and quantification of the thrombin-activated canine platelet secretome (CAPS), and to compare the CAPS proteins to human and murine platelet proteomic data. Washed platelets were isolated from healthy dogs, and stimulated with saline (control) or gamma-thrombin (releasate). Proteins were separated by SDS-page, trypsin-digested and analyzed by liquid chromatography and tandem mass spectrometry (MS). CAPS proteins were defined as those with a MS1-abundance ratio of two or more for releasate vs. unstimulated saline control. A total of 1,918 proteins were identified, with 908 proteins common to all dogs and 693 characterized as CAPS proteins. CAPS proteins were similar to human and murine platelet secretomes and were highly represented in hemostatic pathways. Differences unique to CAPS included replacement of platelet factor 4 with other cleavage products of platelet basic protein (e.g. interleukin-8), novel proteins (e.g. C-C motif chemokine 14), and proteins in relatively high (e.g. protease nexin-1) or low (e.g. von Willebrand factor) abundance. This study establishes the first in-depth platelet releasate proteome from healthy dogs with a reference database of 693 CAPS proteins. Similarities between CAPS and the human secretome confirm the utility of dogs as translational models of human disease, but we also identify differences unique to canine platelets. Our findings provide a resource for further investigations into disease-related CAPS profiles, and for comparative pathway analyses of platelet activation among species.

Citing Articles

A prospective cohort study to identify clinical diagnostic and prognostic markers of primary immune thrombocytopenia in dogs.

Brooks M, Goggs R, Frye A, Armato J, Forman M, Hertl J J Vet Intern Med. 2024; 38(2):1022-1034.

PMID: 38205735 PMC: 10937499. DOI: 10.1111/jvim.16985.


Molecular Proteomics and Signalling of Human Platelets in Health and Disease.

Huang J, Zhang P, Solari F, Sickmann A, Garcia A, Jurk K Int J Mol Sci. 2021; 22(18).

PMID: 34576024 PMC: 8468031. DOI: 10.3390/ijms22189860.


The canine activated platelet secretome (CAPS): A translational model of thrombin-evoked platelet activation response.

Cremer S, Catalfamo J, Goggs R, Seemann S, Kristensen A, Szklanna P Res Pract Thromb Haemost. 2021; 5(1):55-68.

PMID: 33537530 PMC: 7845059. DOI: 10.1002/rth2.12450.


Platelet proteome changes in dogs with congestive heart failure.

Levent P, Kocaturk M, Akgun E, Saril A, Cevik O, Baykal A BMC Vet Res. 2020; 16(1):466.

PMID: 33256720 PMC: 7708215. DOI: 10.1186/s12917-020-02692-x.

References
1.
Randriamboavonjy V, Isaak J, Elgheznawy A, Pistrosch F, Fromel T, Yin X . Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes. Blood. 2012; 120(2):415-23. DOI: 10.1182/blood-2011-12-399980. View

2.
Durinck S, Spellman P, Birney E, Huber W . Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc. 2009; 4(8):1184-91. PMC: 3159387. DOI: 10.1038/nprot.2009.97. View

3.
Soslau G, Goldenberg S, Class R, Jameson B . Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin. Platelets. 2004; 15(3):155-66. DOI: 10.1080/0953710042000199848. View

4.
Schulz-Knappe P, Schrader M, Standker L, Richter R, Hess R, Jurgens M . Peptide bank generated by large-scale preparation of circulating human peptides. J Chromatogr A. 1997; 776(1):125-32. DOI: 10.1016/s0021-9673(97)00152-0. View

5.
Capriotti A, Caruso G, Cavaliere C, Piovesana S, Samperi R, Lagana A . Proteomic characterization of human platelet-derived microparticles. Anal Chim Acta. 2013; 776:57-63. DOI: 10.1016/j.aca.2013.03.023. View